Literature DB >> 31657388

Targeting immune checkpoint B7-H3 antibody-chlorin e6 bioconjugates for spectroscopic photoacoustic imaging and photodynamic therapy.

Lipeng Zhu1, Jie Liu, Guangyu Zhou, Hoi Man Ng, Irene L Ang, Guofang Ma, Yubin Liu, Shuo Yang, Fengjuan Zhang, Kai Miao, Terence C W Poon, Xuanjun Zhang, Zhen Yuan, Chu-Xia Deng, Qi Zhao.   

Abstract

In this study, we constructed bioconjugates of targeting immune checkpoint B7-H3 antibody and chlorin e6 to treat non-small cell lung cancer under the guidance of spectroscopic photoacoustic and fluorescence imaging. The B7-H3-Ce6 conjugates could display effective tumor diagnosis and therapy and provide a novel approach for immunotherapy.

Entities:  

Year:  2019        PMID: 31657388     DOI: 10.1039/c9cc06839b

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.

Authors:  Jie Liu; Shuo Yang; Bihui Cao; Guangyu Zhou; Fengjuan Zhang; Yuan Wang; Rixin Wang; Lipeng Zhu; Ya Meng; Cong Hu; Hui Liang; Xu Lin; Kangshun Zhu; Guokai Chen; Kathy Qian Luo; Lijun Di; Qi Zhao
Journal:  J Hematol Oncol       Date:  2021-01-29       Impact factor: 17.388

2.  Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis.

Authors:  Lipeng Zhu; Yunlu Dai; Lizeng Gao; Qi Zhao
Journal:  Int J Nanomedicine       Date:  2021-07-05

Review 3.  B7-H3, a checkpoint molecule, as a target for cancer immunotherapy.

Authors:  Shuo Yang; Wei Wei; Qi Zhao
Journal:  Int J Biol Sci       Date:  2020-03-25       Impact factor: 6.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.